Sexual Health
The Medical Center is focused on the importance of sexual health as part of overall health and wellness. We offer comprehensive sexual health screenings tailored to your needs and concerns. In addition to urine and blood tests, we can offer three-site swab tests for additional peace of mind. Your STI test results will be available quickly—sometimes on the same day.
Screening & Treatment Services
- Screening for STIs – HIV, HPV, Chlamydia, Gonorrhea, Syphilis, Hepatitis, Trichomoniasis & more
- Diagnosis and treatment for STIs for those who have had an exposure
- Diagnosis and treatment for symptomatic STIs
Prevention Services
- Prevention education and risk reduction counseling
- PrEP (pre-exposure prophylaxis) for HIV prevention, including both pill and injectable options
- PEP (post-exposure prophylaxis) treatment to prevent HIV infection after an exposure has occurred
- DoxyPEP to prevent STIs after an exposure has occurred
Vaccinations
- Mpox
- Hepatitis A and B
- Human papillomavirus (HPV)
- Meningitis
HPV Cervical Cancer Screening
At Bergen New Bridge Medical Center, we lead the way in HPV cervical cancer screening, transforming healthcare one test at a time. Join us in our mission to prioritize your health and well-being.
Our laboratory is proud to offer testing for patients at high risk for Human Papillomavirus (HPV) with extended genotyping, a cutting-edge method for cervical cancer diagnosis.
Recently, the American Society for Colposcopy and Cervical Pathology (ASCCP) released final guidelines endorsing extended genotyping as a superior method for risk assessment compared to traditional HPV testing. This advancement allows for more precise patient management, ensuring tailored care plans for individuals at every step of their journey.
As pioneers in this field, we are thrilled to incorporate extended genotyping into our screening protocols using the BD Onclarity™ HPV Assay. This state-of-the-art test provides unparalleled accuracy in determining patient management strategies, leading to improved outcomes and peace of mind for our patients.
Our commitment to excellence extends beyond testing. We are dedicated to empowering clinicians with the latest tools and information through updates to our mobile application. With these advancements, we anticipate a widespread adoption of extended genotyping in clinical practice, ensuring that more individuals receive the personalized care they deserve.
Introducing Self-Collection for HPV Testing: A New Era in Women's Health at Bergen New Bridge Medical Center
We are excited to announce the FDA approval of the BD Onclarity™ HPV Extended Genotype Assay, which now includes the option for vaginal swab self-collection in a healthcare setting. As the only HPV test offering self-collection and extended genotyping, this innovative approach is set to revolutionize patient care and enhance our women's health services.
Why Our HPV Self-Collection Test Is a Game-Changer
- Convenience: Patients can collect their samples in the privacy and comfort of a healthcare setting, reducing the need for a full pelvic exam and alleviating potential embarrassment.
- Accuracy: The test boasts high sensitivity and specificity, providing reliable results for superior patient care.
- Accessibility: By eliminating barriers to screening, we can reach more individuals, particularly those who may have postponed or avoided testing in the past.
Experience the benefits of advanced HPV testing at Bergen New Bridge and take charge of your health confidently and easily.
For more information, read the BD article on cervical cancer screening.
For Providers Interested In Using This Advanced Screening
Contact:
Laboratory Director Ilham Atir
201-967-4000 ext. 54062
iatir@newbridgehealth.org.
Download BD Onclarity™ HPV Assay Information
